SEC Info - Cypress Bioscience Inc - ‘10-K’ for 12/31/09

SEC Info℠

Home

Help

Please Sign In

Cypress Bioscience Inc – ‘10-K’ for 12/31/09 – ‘EX-23.1’

On: Tuesday, 3/30/10, at 9:40pm ET · As of: 3/31/10 · For: 12/31/09 · Accession #: 950123-10-30260 · File #: 0-12943

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/31/10  Cypress Bioscience Inc            10-K       12/31/09   10:795K                                   Donnelley … Solutions/FA

Annual Report — Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    594K 
 2: EX-10.18    Material Contract                                   HTML     38K 
 3: EX-10.19    Material Contract                                   HTML     13K 
 4: EX-10.20    Material Contract                                   HTML     18K 
 5: EX-10.21    Material Contract                                   HTML     25K 
 6: EX-21.1     Subsidiaries                                        HTML      6K 
 7: EX-23.1     Consent of Experts or Counsel                       HTML      8K 
 8: EX-31.1     Certification -- Sarbanes-Oxley Act - Sect. 302     HTML     12K 
 9: EX-31.2     Certification -- Sarbanes-Oxley Act - Sect. 302     HTML     12K 
10: EX-32       Certification -- Sarbanes-Oxley Act - Sect. 906     HTML     10K

EX-23.1 — Consent of Experts or Counsel

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

exv23w1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 333-01071, 333-04323, 333-15483, 333-39759, 333-66269, 333-87038, 333-104954, 333-110158 and 333-124779, and Form S-8 Nos. 333-06771, 333-06765, 333-19465, 333-59164, 333-88544, 333-116662, 333-147258 and 333-161264) of Cypress Bioscience, Inc. and in the related Prospectus of our reports dated March 30, 2010 with respect to the consolidated financial statements of Cypress Bioscience, Inc., and the effectiveness of internal control over financial reporting of Cypress Bioscience, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2009.

/s/ Ernst & Young LLP

San Diego, California
March 30, 2010

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-K’ Filing	Date	Other Filings

Filed as of:	3/31/10	10-Q, 8-K
Filed on:	3/30/10
For Period End:	12/31/09	NT 10-K
		List all Filings

↑Top

Filing Submission 0000950123-10-030260 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)